Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A novel substrate mimetic inhibitor of PKB/Akt inhibits prostate cancer tumor growth in mice by blocking the PKB pathway.
Biochemistry. 2007 Apr 24;46(16):4716-24. doi: 10.1021/bi061928s. Epub 2007 Mar 31.
Biochemistry. 2007.
PMID: 17397140
Toward a PKB inhibitor: modification of a selective PKA inhibitor by rational design.
Reuveni H, Livnah N, Geiger T, Klein S, Ohne O, Cohen I, Benhar M, Gellerman G, Levitzki A.
Reuveni H, et al. Among authors: ohne o.
Biochemistry. 2002 Aug 13;41(32):10304-14. doi: 10.1021/bi0202530.
Biochemistry. 2002.
PMID: 12162746
Item in Clipboard
A novel cytidine analog, RX-3117, shows potent efficacy in xenograft models, even in tumors that are resistant to gemcitabine.
Yang MY, Lee YB, Ahn CH, Kaye J, Fine T, Kashi R, Ohne O, Smid K, Peters GJ, Kim DJ.
Yang MY, et al. Among authors: ohne o.
Anticancer Res. 2014 Dec;34(12):6951-9.
Anticancer Res. 2014.
PMID: 25503121
Item in Clipboard
Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360).
Peters GJ, Smid K, Vecchi L, Kathmann I, Sarkisjan D, Honeywell RJ, Losekoot N, Ohne O, Orbach A, Blaugrund E, Jeong LS, Lee YB, Ahn CH, Kim DJ.
Peters GJ, et al. Among authors: ohne o.
Invest New Drugs. 2013 Dec;31(6):1444-57. doi: 10.1007/s10637-013-0025-x. Epub 2013 Sep 19.
Invest New Drugs. 2013.
PMID: 24048768
Item in Clipboard
Cite
Cite